The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs and male first-catch urine and urethral swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® System
Study Type
OBSERVATIONAL
Enrollment
1,492
APTIMA Assays; PANTHER System
University of Alabama at Birmingham
Birmingham, Alabama, United States
Anthony Mills MD Inc.
Los Angeles, California, United States
Qualitative detection of ribosomal RNA from Chlamydia trachomatis and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease
Time frame: approximately one year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Benchmark Research
San Francisco, California, United States
Planned Parenthood Southern New England
New Haven, Connecticut, United States
AGA Clinical Trials
Hialeah, Florida, United States
Wishard Health Services
Indianapolis, Indiana, United States
Louisiana State University Health Sciences
New Orleans, Louisiana, United States
John Hopkins University
Baltimore, Maryland, United States
New England Center for Clinical Research - New Bedford Clinic
New Bedford, Massachusetts, United States
Hennepin County Medical Center
Minneapolis, Minnesota, United States
...and 6 more locations